NYSE$ENOV
Enovis Corp · Q2 2023 earnings
Q2 2023 earnings · · Investor relations
Briefing
Enovis' Q2 2023 results demonstrated strong momentum with sales growth and EBITDA margin expansion.
Enovis reported strong second-quarter results with 8% sales growth and significant EBITDA margin expansion. The reconstructive segment grew by 18%, and the prevention and recovery segment grew by 4%. The company has raised its full-year outlook for revenue and adjusted EPS.
- Second quarter sales grew by 8% with strong EBITDA margin expansion.
- Reconstructive segment experienced organic growth of 17%.
- Prevention and Recovery segment grew by 4% organically.
- Net loss from continuing operations was $0.27 per share, with adjusted EPS of $0.61.
Headline financials
Revenue & EPS history
Enovis · Revenue · Quarterly
$429M
Revenue by segment
Enovis · $131M total across 1 segment · Q2 2022
- Reconstructive$131M—100.0%
Forward guidance
Enovis updated its financial expectations for 2023.
Tailwinds
- Revenue is expected to organically grow 7-7.5% from the prior year versus prior expectations of 6-7% growth.
- Adjusted EBITDA is forecasted to be $262-$270 million as compared with the previous outlook of $259-$267 million.
- Full-year adjusted earnings per diluted share guidance from $2.18-$2.32 to $2.22-$2.36.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2023
+1.6%
Avg return
Earnings day
+1.3%
Avg return
5 days after
+0.1%
Avg return
30 days after
52%
33 / 64 earnings
Positive
+21.3%
Q3 2011
Best reaction
-18.7%
Q1 2016
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +9.7% | +4.0% | -4.5% | |
| Q4 2025 | +13.8% | +13.3% | -2.2% | |
| Q3 2025 | -9.7% | +0.1% | -14.2% | |
| Q1 2025 | -2.9% | +9.1% | -7.2% | |
| Q4 2024 | -4.9% | -10.1% | -10.3% | |
| Q3 2024 | +10.6% | +9.3% | +10.0% | |
| Q2 2024 | +4.0% | +1.0% | +3.5% | |
| Q1 2024 | -7.5% | -5.7% | -9.3% | |
| Q4 2023 | +4.3% | +2.0% | -0.1% | |
| Q3 2023 | +4.0% | +3.2% | +8.8% | |
| Q2 2023 | -5.6% | -8.1% | -10.0% | |
| Q1 2023 | -1.8% | -3.7% | -3.9% | |
| Q4 2022 | -9.6% | -6.4% | -18.9% | |
| Q3 2022 | -3.4% | +7.4% | +15.9% | |
| Q2 2022 | -3.7% | -4.4% | -17.5% | |
| Q1 2022 | +5.7% | +5.9% | +7.4% | |
| Q4 2021 | +0.9% | +2.8% | -3.7% | |
| Q3 2021 | +0.4% | -1.4% | -14.9% | |
| Q2 2021 | +3.6% | +2.1% | +8.5% | |
| Q1 2021 | -1.1% | -5.9% | -3.2% | |
| Q4 2020 | +13.7% | +17.2% | +16.8% | |
| Q3 2020 | -4.1% | +3.0% | +30.8% | |
| Q2 2020 | +6.8% | +13.0% | +8.1% | |
| Q1 2020 | +14.6% | +6.6% | +33.4% | |
| Q4 2019 | +2.8% | -5.1% | -55.3% | |
| Q3 2019 | +9.6% | +11.5% | +6.0% | |
| Q2 2019 | +7.9% | +5.3% | +15.1% | |
| Q1 2019 | -5.5% | -6.5% | -4.7% | |
| Q4 2018 | +5.3% | +6.8% | +15.0% | |
| Q3 2018 | -0.3% | +0.8% | -12.5% | |
| Q2 2018 | +5.5% | +0.8% | +12.9% | |
| Q1 2018 | +2.2% | +5.3% | +1.1% | |
| Q4 2017 | -8.5% | -14.2% | -11.2% | |
| Q3 2017 | -12.7% | -13.7% | -14.0% | |
| Q2 2017 | +1.1% | +0.9% | -4.3% | |
| Q1 2017 | +1.9% | +2.4% | +7.4% | |
| Q4 2016 | +2.2% | -0.5% | -5.0% | |
| Q3 2016 | +7.8% | +5.4% | +26.9% | |
| Q2 2016 | +0.0% | -3.2% | +3.4% | |
| Q1 2016 | -18.7% | — | — | |
| Q4 2015 | +18.9% | — | — | |
| Q3 2015 | -6.5% | — | — | |
| Q2 2015 | -5.1% | — | — | |
| Q1 2015 | -0.8% | — | — | |
| Q4 2014 | -0.9% | — | — | |
| Q3 2014 | -5.1% | — | — | |
| Q2 2014 | -6.9% | — | — | |
| Q1 2014 | -3.4% | — | — | |
| Q4 2013 | +7.0% | — | — | |
| Q3 2013 | +0.0% | — | — | |
| Q2 2013 | -0.1% | — | — | |
| Q1 2013 | +4.5% | — | — | |
| Q4 2012 | -5.8% | — | — | |
| Q3 2012 | -2.7% | — | — | |
| Q2 2012 | +5.2% | — | — | |
| Q1 2011 | -5.7% | — | — | |
| Q1 2012 | +1.3% | — | — | |
| Q4 2011 | -1.9% | — | — | |
| Q3 2011 | +21.3% | — | — | |
| Q2 2011 | +16.2% | — | — | |
| Q4 2010 | +16.2% | — | — | |
| Q2 2010 | +16.2% | — | — | |
| Q3 2010 | +1.0% | — | — | |
| Q1 2010 | +0.0% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro